{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:07:24Z","timestamp":1773652044261,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>India has made substantial progress in reducing Plasmodium falciparum malaria cases and has set a target to eliminate malaria by 2030. Although artemisinin-based combination therapy (ACT) treatment remains effective, tracking regional differences in genetic variants associated with antimalarial resistance is required for effective drug policy implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 238 P. falciparum clinical samples from 6 Indian states by sequencing 15 parasite genes associated with reduced drug effectiveness. The method involved nanopore sequencing of target gene amplicons derived from dried blood spots using a highly-sensitive PfMDR15 surveillance panel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>India's historical policy of artesunate-sulfadoxine-pyrimethamine in central India and artemether-lumefantrine in the Northeast has shaped contrasting resistance profiles. In the Northeast, chloroquine resistance persisted at high frequency (Pfcrt K76T and CVIET haplotype; Pfaat1 S258L), alongside quintuple and sextuple Pfdhfr\u2013Pfdhps haplotypes conferring complete sulfadoxine\u2013pyrimethamine resistance. Central India showed variable chloroquine resistance (parasites largely retained wild-type Pfcrt) and emerging lumefantrine tolerance (Pfmdr1 Y184F, Pfaat1 S258L). Interestingly, Delhi (Central India) parasites resembled profiles from the distant Northeast, which borders South East Asia. The detection of Pfaat1 S258L, previously reported only from Africa and associated with reduced lumefantrine susceptibility, suggests convergent evolution under ACT partner-drug pressure. No WHO-validated Pfk13 artemisinin resistance mutations were detected, supporting continued efficacy of ACT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>India's resistance landscape is fragmented, with signals of expanding lumefantrine tolerance and importation or evolution of globally relevant mutations. These findings highlight the importance of integrating molecular genomic surveillance into malaria control policy to monitor and protect ACT effectiveness and advance malaria elimination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag106","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:40:34Z","timestamp":1772109634000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeted Genomic Surveillance Unveils Genetic Variations Linked to Regional Malaria Drug Resistance Dynamics in India"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-8747","authenticated-orcid":false,"given":"Ajinkya","family":"Khilari","sequence":"first","affiliation":[{"name":"Biochemical Sciences Division, CSIR \u2013 National Chemical Laboratory , Pune ,","place":["India"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , Ghaziabad, Uttar Pradesh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-6472","authenticated-orcid":false,"given":"Shweta","family":"Sharma","sequence":"additional","affiliation":[{"name":"International Centre for Genetic Engineering and Biotechnology , New Delhi, Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3541-9122","authenticated-orcid":false,"given":"Manali","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Biochemical Sciences Division, CSIR \u2013 National Chemical Laboratory , Pune ,","place":["India"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , Ghaziabad, Uttar Pradesh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-5826","authenticated-orcid":false,"given":"Anju","family":"Viswan K","sequence":"additional","affiliation":[{"name":"ICMR-Vector Control Research Centre , Puducherry ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-5121","authenticated-orcid":false,"given":"Rini","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"International Centre for Genetic Engineering and Biotechnology , New Delhi, Delhi ,","place":["India"]},{"name":"Microbiology, All India Institute of Medical Sciences , New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-9426","authenticated-orcid":false,"given":"Bijay R","family":"Mirdha","sequence":"additional","affiliation":[{"name":"Microbiology, All India Institute of Medical Sciences , New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-0935","authenticated-orcid":false,"given":"Manju","family":"Rahi","sequence":"additional","affiliation":[{"name":"ICMR-Vector Control Research Centre , Puducherry ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-0034","authenticated-orcid":false,"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"International Centre for Genetic Engineering and Biotechnology , New Delhi, Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-4846","authenticated-orcid":false,"given":"Dhanasekaran","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Biochemical Sciences Division, CSIR \u2013 National Chemical Laboratory , Pune ,","place":["India"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , Ghaziabad, Uttar Pradesh ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2026031604314032900_ofag106-B1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.actatropica.2005.04.015","article-title":"Public health impact of drug-resistant Plasmodium falciparum malaria","volume":"94","author":"Bj\u00f6rkman","year":"2005","journal-title":"Acta Trop"},{"key":"2026031604314032900_ofag106-B2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.lanmic.2025.101073","article-title":"WHO world malaria report 2024","volume":"6","author":"Venkatesan","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026031604314032900_ofag106-B3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-030-46020-4_2","volume-title":"Remote Sensing for Malaria: Monitoring and Predicting Malaria from Operational Satellites","author":"Kogan","year":"2020"},{"key":"2026031604314032900_ofag106-B4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2026031604314032900_ofag106-B5","doi-asserted-by":"crossref","first-page":"668574","DOI":"10.3389\/fgene.2021.668574","article-title":"Chloroquine and sulfadoxine-pyrimethamine resistance in sub-Saharan Africa: a review","volume":"12","author":"Roux","year":"2021","journal-title":"Front Genet"},{"key":"2026031604314032900_ofag106-B6","doi-asserted-by":"crossref","first-page":"a025619","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026031604314032900_ofag106-B7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.52403\/ijhsr.20230722","article-title":"Ending malaria in India by 2030: a comprehensive overview of progress, challenges and strategies","volume":"13","author":"Pahari","year":"2023","journal-title":"Int J Health Sci Res"},{"key":"2026031604314032900_ofag106-B8","author":"Directorate of National Vector Borne Diseases Control Programme"},{"key":"2026031604314032900_ofag106-B9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi","volume":"355","author":"Laufer","year":"2006","journal-title":"N Engl J Med"},{"key":"2026031604314032900_ofag106-B10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-8-106","article-title":"Chloroquine resistance before and after its withdrawal in Kenya","volume":"8","author":"Mwai","year":"2009","journal-title":"Malar J"},{"key":"2026031604314032900_ofag106-B11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2026031604314032900_ofag106-B12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12936-016-1641-7","article-title":"Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification","volume":"15","author":"Oyola","year":"2016","journal-title":"Malar J"},{"key":"2026031604314032900_ofag106-B13","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","article-title":"Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana","volume":"8","author":"Girgis","year":"2023","journal-title":"Nat Microbiol"},{"key":"2026031604314032900_ofag106-B14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41467-024-45688-z","article-title":"Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing","volume":"15","author":"de Cesare","year":"2024","journal-title":"Nat Commun"},{"key":"2026031604314032900_ofag106-B15","unstructured":"MalariaGEN\n          . DBS01: Dried Blood Spot (DBS) Collection Protocol. Version 1.2. Oxford: MalariaGEN; 2021."},{"key":"2026031604314032900_ofag106-B16","doi-asserted-by":"crossref","first-page":"e0326243","DOI":"10.1371\/journal.pone.0326243","article-title":"Identification of genetic variations linked to buparvaquone resistance in Theileria annulata infecting dairy cattle in India","volume":"20","author":"Musale","year":"2025","journal-title":"PLoS One"},{"key":"2026031604314032900_ofag106-B17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0166-6851(93)90050-8","article-title":"Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections","volume":"58","author":"Snounou","year":"1993","journal-title":"Mol Biochem Parasitol"},{"key":"2026031604314032900_ofag106-B18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nprot.2017.066","article-title":"Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples","volume":"12","author":"Quick","year":"2017","journal-title":"Nat Protoc"},{"key":"2026031604314032900_ofag106-B19","doi-asserted-by":"crossref","first-page":"veaf090","DOI":"10.1093\/ve\/veaf090","article-title":"Detection and variant characterization of lumpy skin disease virus from dairy cattle in India","volume":"11","author":"Bajpai","year":"2025","journal-title":"Virus Evol"},{"key":"2026031604314032900_ofag106-B20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","article-title":"Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019 and \u2018super resistant\u2019 malaria","volume":"29","author":"Naidoo","year":"2013","journal-title":"Trends Parasitol"},{"key":"2026031604314032900_ofag106-B21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","article-title":"Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study","volume":"23","author":"Beshir","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026031604314032900_ofag106-B22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/504269","article-title":"Occurrence of the Southeast Asian\/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania","volume":"193","author":"Alifrangis","year":"2006","journal-title":"J Infect Dis"},{"key":"2026031604314032900_ofag106-B23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12936-022-04403-3","article-title":"Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India","volume":"21","author":"Rana","year":"2022","journal-title":"Malar J"},{"key":"2026031604314032900_ofag106-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/jiaf068","article-title":"Prevalence of Plasmodium falciparum drug resistance markers Pfcrt K76T and Pfaat1 S258L in southern Rwanda, 2010\u20132023","volume":"232","author":"Schallenberg","year":"2025","journal-title":"J Infect Dis"},{"key":"2026031604314032900_ofag106-B25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","article-title":"Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1","volume":"8","author":"Amambua-Ngwa","year":"2023","journal-title":"Nat Microbiol"},{"key":"2026031604314032900_ofag106-B26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S0031182018001609","article-title":"Molecular investigation of the Pfmdr1 gene of Plasmodium falciparum isolates in Henan Province imported from Africa","volume":"146","author":"Yang","year":"2019","journal-title":"Parasitology"},{"key":"2026031604314032900_ofag106-B27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","article-title":"Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors","volume":"18","author":"Ocan","year":"2019","journal-title":"Malar J"},{"key":"2026031604314032900_ofag106-B28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpddr.2017.06.002","article-title":"Progressive increase in point mutations associated with chloroquine resistance: even after withdrawal of chloroquine use in India","volume":"7","author":"Das","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026031604314032900_ofag106-B29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13071-022-05239-1","article-title":"Evaluations of candidate markers of dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum isolates from the China\u2013Myanmar, Thailand\u2013Myanmar and Thailand\u2013Cambodia borders","volume":"15","author":"Ye","year":"2022","journal-title":"Parasit Vectors"},{"key":"2026031604314032900_ofag106-B30","doi-asserted-by":"crossref","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","article-title":"Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr1 gene affecting susceptibility to artemether\u2013lumefantrine and artesunate\u2013amodiaquine in Africa","volume":"3","author":"Okell","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2026031604314032900_ofag106-B31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/cid\/ciz166","article-title":"Lack of convincing evidence of artemisinin resistance in India","volume":"69","author":"Rasmussen","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026031604314032900_ofag106-B32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpddr.2023.05.003","article-title":"Genomic analysis of Indian isolates of Plasmodium falciparum: implications for drug resistance and virulence factors","volume":"22","author":"Choubey","year":"2023","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026031604314032900_ofag106-B33","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1038\/s41467-025-59946-1","article-title":"Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion","volume":"16","author":"Verschuuren","year":"2025","journal-title":"Nat Commun."},{"key":"2026031604314032900_ofag106-B34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","article-title":"Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase","volume":"94","author":"Sirawaraporn","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026031604314032900_ofag106-B35","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1038\/s41598-018-26334-3","article-title":"Nanopore sequencing of drug-resistance-associated genes in Plasmodium falciparum","volume":"8","author":"Runtuwene","year":"2018","journal-title":"Sci Rep"},{"key":"2026031604314032900_ofag106-B36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpddr.2016.08.004","article-title":"Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V","volume":"6","author":"Oguike","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026031604314032900_ofag106-B37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.meegid.2012.12.014","article-title":"Mutation analysis in pfmdr1 and pfmrp1 as potential candidate genes for artemisinin resistance in Plasmodium falciparum clinical isolates 4 years after implementation of artemisinin combination therapy in Iran","volume":"14","author":"Pirahmadi","year":"2013","journal-title":"Infect Genet Evol"},{"key":"2026031604314032900_ofag106-B38","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/AAC.05618-11","article-title":"The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates","volume":"56","author":"Briolant","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026031604314032900_ofag106-B39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2026031604314032900_ofag106-B40","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","article-title":"Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6","volume":"366","author":"Jambou","year":"2005","journal-title":"Lancet"},{"key":"2026031604314032900_ofag106-B41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jb\/mvab070","article-title":"Functional analyses of plasmodium ferredoxin Asp97Tyr mutant related to artemisinin resistance of human malaria parasites","volume":"170","author":"Kimata-Ariga","year":"2021","journal-title":"J Biochem"},{"key":"2026031604314032900_ofag106-B42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12936-022-04330-3","article-title":"Apicoplast ribosomal protein S10-V127M enhances artemisinin resistance of a Kelch13 transgenic Plasmodium falciparum","volume":"21","author":"Kampoun","year":"2022","journal-title":"Malar J"},{"key":"2026031604314032900_ofag106-B43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026031604314032900_ofag106-B44","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1074\/jbc.M111.324319","article-title":"Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression","volume":"287","author":"Fisher","year":"2012","journal-title":"J Biol Chem"},{"key":"2026031604314032900_ofag106-B45","doi-asserted-by":"crossref","first-page":"e85023","DOI":"10.7554\/eLife.85023","article-title":"Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance","volume":"12","author":"Mandt","year":"2023","journal-title":"eLife"},{"key":"2026031604314032900_ofag106-B46","doi-asserted-by":"crossref","first-page":"16192","DOI":"10.1074\/jbc.273.26.16192","article-title":"The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin","volume":"273","author":"Bhisutthibhan","year":"1998","journal-title":"J Biol Chem"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag106\/67202902\/ofag106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag106\/67202902\/ofag106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag106\/67202902\/ofag106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:31:53Z","timestamp":1773649913000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag106\/8503703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag106","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"ofag106"}}